Cargando…
Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy
The world is currently facing a novel coronavirus (SARS-CoV-2) pandemic. The greatest threat that is disrupting the normal functioning of society is the exceptionally high species independent transmission. Drug repurposing is understood to be the best strategy to immediately deploy well-characterize...
Autores principales: | Gupta, Yash, Maciorowski, Dawid, Zak, Samantha E., Kulkarni, Chandrashekhar V., Herbert, Andrew S., Durvasula, Ravi, Fareed, Jawed, Dye, John M., Kempaiah, Prakasha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074525/ https://www.ncbi.nlm.nih.gov/pubmed/33915212 http://dx.doi.org/10.1016/j.ijbiomac.2021.04.148 |
Ejemplares similares
-
A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19
por: Maciorowski, Dawid, et al.
Publicado: (2020) -
Repurposing Lansoprazole and Posaconazole to treat leishmaniasis: Integration of in vitro testing, pharmacological corroboration, and mechanisms of action
por: Gupta, Yash, et al.
Publicado: (2022) -
Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays
por: Gupta, Yash, et al.
Publicado: (2021) -
Antiviral evaluation of hydroxyethylamine analogs: Inhibitors of SARS-CoV-2 main protease (3CLpro), a virtual screening and simulation approach
por: Gupta, Yash, et al.
Publicado: (2021) -
Therapeutic and Vaccine Options for COVID-19: Status after Six Months of the Disease Outbreak
por: Maciorowski, Dawid, et al.
Publicado: (2021)